Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies.

ABSTRACT:

Background

Type 2 diabetes represents an increasingly critical challenge for health policy worldwide. It absorbs massive resources from both patients and national economies to sustain direct costs of the treatment of type 2 diabetes and its complications and indirect costs related to work loss and wages. More recently, there are innovations based on remote control and personalised programs that promise a more cost-effective diabetes management while reducing diabetes-related complications. In such a context, this work attempts to update cost analysis reviews on type 2 diabetes, focusing on France and Germany, in order to explore most significant cost drivers and cost-saving opportunities through innovations in diabetes care. Although both countries approach care delivery differentl

SUBMITTER: Stegbauer C 

PROVIDER: S-EPMC7667793 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature